Incarceration and injection drug use in Baltimore, Maryland

Addiction

Volumn 110, Issue 7, 2015, Pages 1152-1159

  Genberg, Becky L ^a   Astemborski, Jacquie ^b   Vlahov, David ^c   Kirk, Gregory D ^b   Mehta, Shruti H ^b  

^a BROWN UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HIV; Incarceration; Injection drug use; Longitudinal analysis; Observational study; Relapse

Indexed keywords

ADULT; AFRICAN AMERICAN; COHORT ANALYSIS; CONFIDENCE INTERVAL; ETHNOLOGY; ETIOLOGY; FEMALE; FOLLOW UP; HIV SEROPOSITIVITY; HUMAN; LONGITUDINAL STUDY; MALE; MARYLAND; PRISONER; PROSPECTIVE STUDY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SUBSTANCE ABUSE;

ADULT; AFRICAN AMERICANS; BALTIMORE; COHORT STUDIES; CONFIDENCE INTERVALS; FEMALE; FOLLOW-UP STUDIES; HIV SEROPOSITIVITY; HUMANS; LONGITUDINAL STUDIES; MALE; PRISONERS; PROSPECTIVE STUDIES; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84931578378     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12938     Document Type: Article

References (24)

1. Moore L. D., Elkavich A. Who's using and who's doing time: incarceration, the war on drugs, and public health. Am J Public Health 2008; 98: 782-6.
2. Carson E. A., Sabol W. J. Prisoners in 2011. Washington, DC: US Department of Justice, Bureau of Justice Statistics; 2012.
3. Schiraldi V., Ziedenberg J. Race and Incarceration in Maryland. Washington, DC: Justice Policy Insitute; 2003.
4. Milloy M. J., Wood E., Small W., Tyndall M., Lai C., Montaner J. et al. Incarceration experiences in a cohort of active injection drug users. Drug Alcohol Rev 2008; 27: 693-9.
5. Galai N., Safaeian M., Vlahov D., Bolotin A., Celentano D. D. Longitudinal patterns of drug injection behavior in the ALIVE Study cohort, 1988-2000: description and determinants. Am J Epidemiol 2003; 158: 695-704.
6. Alcabes P., Vlahov D., Anthony J. C. Characteristics of intravenous drug users by history of arrest and treatment for drug use. J Nerv Ment Dis 1992; 180: 48-54.
7. Sheu M., Hogan J., Allsworth J., Stein M., Vlahov D., Schoenbaum E. E. et al. Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women. J Womens Health (Larchmt) 2002; 11: 743-50.
8. Milloy M. J., Buxton J., Wood E., Li K., Montaner J. S., Kerr T. Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis. BMC Public Health 2009; 9: 156. doi: 10.1186/1471-2458-9-156
9. Binswanger I. A., Blatchford P. J., Mueller S. R., Stern M. F. Mortality after prison release: opioid overdose and other causes of death, risk factors, and time trends from 1999 to 2009. Ann Intern Med 2013; 159: 592-600.
10. Merrall E. L., Kariminia A., Binswanger I. A., Hobbs M. S., Farrell M., Marsden J. et al. Meta-analysis of drug-related deaths soon after release from prison. Addiction 2010; 105: 1545-1554.
11. Vlahov D., Anthony J. C., Munoz A., Margolick J., Nelson K. E., Celentano D. D. et al. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991; 109: 75-100.
12. Genberg B. L., Gange S. J., Go V. F., Celentano D. D., Kirk G. D., Latkin C. A. et al. The effect of neighborhood deprivation and residential relocation on long-term injection cessation among injection drug users (IDUs) in Baltimore, Maryland. Addict 2011; 106: 1966-74.
13. DeBeck K., Kerr T., Li K., Milloy M. J., Montaner J., Wood E. Incarceration and drug use patterns among a cohort of injection drug users. Addiction 2009; 104: 69-76.
14. Pollini R. A., Alvelais J., Gallardo M., Vera A., Lozada R., Magis-Rodriquez C. et al. The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug Alcohol Depend 2009; 103: 52-8.
15. Kang S. Y., Deren S., Andia J., Colon H. M., Robles R., Oliver-Velez D. HIV transmission behaviors in jail/prison among Puerto Rican drug injectors in New York and Puerto Rico. AIDS Behav 2005; 9: 377-86.
16. Wood E., Li K., Small W., Montaner J. S., Schechter M. T., Kerr T. Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep 2005; 120: 150-6.
17. Freudenberg N., Daniels J., Crum M., Perkins T., Richie B. E. Coming home from jail: the social and health consequences of community reentry for women, male adolescents, and their families and communities. Am J Public Health 2005; 95: 1725-36.
18. Latkin C. A., Vlahov D., Anthony J. C. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction 1993; 88: 517-26.
19. Rich J. D., McKenzie M., Shield D. C., Wolf F. A., Key R. G., Poshkus M. et al. Linkage with methadone treatment upon release from incarceration: a promising opportunity. J Addict Dis 2005; 24: 49-59.
20. Rich J. D., Holmes L., Salas C., Macalino G., Davis D., Ryczek J. et al. Successful linkage of medical care and community services for HIV-positive offenders being released from prison. J Urban Health 2001; 78: 279-89.
21. McVay D., Schiraldi V., Ziedenberg J. Treatment or Incarceration? National and State Findings on the Efficacy and Cost Savings of Drug Treatment Versus Imprisonment. Washington, DC: Justice Policy Institute; 2004.
22. Degenhardt L., Larney S., Kimber J., Gisev N., Farrell M., Dobbins T. et al. The impact of opioid substitution therapy on mortality on post-release from prison: retrospective data linkage study. Addiction 2014; 109: 1306-1317.
23. Cropsey K. L., Binswanger I. A., Clark C. B., Taxman F. S. The unmet medical needs of correctional populations in the United States. J Natl Med Assoc 2012; 104: 487-92.
24. Nunn A., Zaller N., Dickman S., Trimbur C., Nijhawan A., Rich J. D. Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey. Drug Alcohol Depend 2009; 105: 83-8.